A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure. [electronic resource]
Producer: 20110823Description: 560-8 p. digitalISSN:- 1879-0844
- Algorithms
- Angioplasty, Balloon, Coronary
- Double-Blind Method
- Erythropoietin -- administration & dosage
- Exercise Tolerance
- Female
- Heart Failure -- complications
- Hemoglobins -- analysis
- Humans
- Male
- Middle Aged
- Myocardial Ischemia -- complications
- Oxygen Consumption
- Pilot Projects
- Recombinant Proteins
- Stroke Volume
- Ventricular Function, Left
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.